Mingjun Bi

841 total citations
13 papers, 270 citations indexed

About

Mingjun Bi is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mingjun Bi has authored 13 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Mingjun Bi's work include Cancer-related molecular mechanisms research (4 papers), Animal Genetics and Reproduction (3 papers) and Cancer-related gene regulation (3 papers). Mingjun Bi is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Animal Genetics and Reproduction (3 papers) and Cancer-related gene regulation (3 papers). Mingjun Bi collaborates with scholars based in China and United States. Mingjun Bi's co-authors include Bin Huang, Hongmei Yu, Zhijie Liu, Lizhen Chen, Zhao Zhang, Mingqiu Chen, Li Li, Pingping Liu, Wenyue Su and Tim H.‐M. Huang and has published in prestigious journals such as Molecular Cell, PLoS ONE and Gene.

In The Last Decade

Mingjun Bi

13 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjun Bi China 9 218 78 53 50 18 13 270
Noa Stettner Israel 5 231 1.1× 163 2.1× 30 0.6× 46 0.9× 20 1.1× 7 358
Ellen M. Beasley United States 6 327 1.5× 44 0.6× 43 0.8× 33 0.7× 20 1.1× 7 380
A. A. Dar India 5 224 1.0× 36 0.5× 76 1.4× 26 0.5× 14 0.8× 7 325
Kana Asano Japan 7 606 2.8× 121 1.6× 35 0.7× 41 0.8× 17 0.9× 9 671
Ewa Błaszczak Poland 7 245 1.1× 37 0.5× 110 2.1× 40 0.8× 12 0.7× 15 345
Guojun Wang China 9 203 0.9× 146 1.9× 12 0.2× 61 1.2× 13 0.7× 13 283
Ziliang Ji China 7 189 0.9× 127 1.6× 15 0.3× 29 0.6× 12 0.7× 9 290
Siniša Bratulić Sweden 10 185 0.8× 31 0.4× 24 0.5× 54 1.1× 18 1.0× 19 280
Liwei Wu China 11 236 1.1× 72 0.9× 22 0.4× 36 0.7× 12 0.7× 34 329
Vanessa Cheung Australia 8 389 1.8× 34 0.4× 25 0.5× 42 0.8× 9 0.5× 11 468

Countries citing papers authored by Mingjun Bi

Since Specialization
Citations

This map shows the geographic impact of Mingjun Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Bi more than expected).

Fields of papers citing papers by Mingjun Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjun Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Bi. The network helps show where Mingjun Bi may publish in the future.

Co-authorship network of co-authors of Mingjun Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjun Bi. A scholar is included among the top collaborators of Mingjun Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjun Bi. Mingjun Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yi, Xianfu, Qingyang Li, Xueying Li, et al.. (2023). The landscape of m1A modification and its posttranscriptional regulatory functions in primary neurons. eLife. 12. 13 indexed citations
2.
Zhang, Zhao, Wei Yu, Dan Tang, et al.. (2020). Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer. RNA Biology. 17(11). 1590–1602. 9 indexed citations
3.
Li, Jieping, et al.. (2020). Feasibility analysis of external application of Xiao-Shuan-San in preventing PICC-related thrombosis. Complementary Therapies in Medicine. 52. 102448–102448. 2 indexed citations
4.
5.
Yang, Mei, Ji Hoon Lee, Zhao Zhang, et al.. (2020). Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor. Cell Reports. 31(12). 107803–107803. 17 indexed citations
6.
Zhu, Chi, Li Li, Zhao Zhang, et al.. (2019). A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer. Molecular Cell. 75(4). 791–806.e8. 82 indexed citations
9.
Xu, Pan, Qiuyan Li, Kai Jiang, et al.. (2016). BAC mediated transgenic Large White boars with FSHα/β genes from Chinese Erhualian pigs. Transgenic Research. 25(5). 693–709. 5 indexed citations
11.
Yang, Yutao, Jiajun Cui, Feng Xue, et al.. (2014). Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(3). 270–281. 34 indexed citations
12.
Bi, Mingjun, Jia Tong, Jing Wang, et al.. (2012). Pituitary-Specific Overexpression of Porcine Follicle-Stimulating Hormone Leads to Improvement of Female Fecundity in BAC Transgenic Mice. PLoS ONE. 7(7). e42335–e42335. 9 indexed citations
13.
Tong, Jia, Hengxi Wei, Xiaofang Liu, et al.. (2010). Production of recombinant human lysozyme in the milk of transgenic pigs. Transgenic Research. 20(2). 417–419. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026